 | • レポートコード：C-GIR20G2827 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「長寿及び抗老化療法の世界市場2019年」は、グローバルにおける長寿及び抗老化療法市場を展望するレポートです。長寿及び抗老化療法のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・長寿及び抗老化療法の市場概観 ・長寿及び抗老化療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・長寿及び抗老化療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・長寿及び抗老化療法の世界市場規模 ・長寿及び抗老化療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・長寿及び抗老化療法のアメリカ市場規模推移 ・長寿及び抗老化療法のカナダ市場規模推移 ・長寿及び抗老化療法のメキシコ市場規模推移 ・長寿及び抗老化療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・長寿及び抗老化療法のドイツ市場規模推移 ・長寿及び抗老化療法のイギリス市場規模推移 ・長寿及び抗老化療法のロシア市場規模推移 ・長寿及び抗老化療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・長寿及び抗老化療法の日本市場規模推移 ・長寿及び抗老化療法の中国市場規模推移 ・長寿及び抗老化療法の韓国市場規模推移 ・長寿及び抗老化療法のインド市場規模推移 ・長寿及び抗老化療法の東南アジア市場規模推移 ・長寿及び抗老化療法の南米市場分析（ブラジル、アルゼンチン等） ・長寿及び抗老化療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・長寿及び抗老化療法の種類別分析/販売量、売上、市場シェア（溶血性薬物療法、遺伝子療法、免疫療法、その他の幹細胞療法） ・長寿及び抗老化療法の用途別分析/市場規模（病院、医療機関、医薬品＆デバイス販売） ・長寿及び抗老化療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・長寿及び抗老化療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Longevity and Anti-senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Longevity and Anti-senescence Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Longevity and Anti-senescence Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Longevity and Anti-senescence Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
CohBar
AgeX Therapeutics，Inc
TA Sciences
Unity Biotechnology
PowerVision Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hemolytic Drug Therapy
Gene Therapy
Immunotherapy
Other Stem Cell Therapies
Market Segment by Applications, can be divided into
Hospital
Medical Service Institution
Drug and Device Sales
Table of Contents
1 Longevity and Anti-senescence Therapy Market Overview
1.1 Product Overview and Scope of Longevity and Anti-senescence Therapy
1.2 Classification of Longevity and Anti-senescence Therapy by Types
1.2.1 Global Longevity and Anti-senescence Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Types in 2018
1.2.3 Hemolytic Drug Therapy
1.2.4 Gene Therapy
1.2.5 Immunotherapy
1.2.6 Other Stem Cell Therapies
1.3 Global Longevity and Anti-senescence Therapy Market by Application
1.3.1 Global Longevity and Anti-senescence Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Medical Service Institution
1.3.4 Drug and Device Sales
1.4 Global Longevity and Anti-senescence Therapy Market by Regions
1.4.1 Global Longevity and Anti-senescence Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Longevity and Anti-senescence Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Longevity and Anti-senescence Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Longevity and Anti-senescence Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Longevity and Anti-senescence Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Longevity and Anti-senescence Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Longevity and Anti-senescence Therapy (2014-2024)
2 Company Profiles
2.1 CohBar
2.1.1 Business Overview
2.1.2 Longevity and Anti-senescence Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 AgeX Therapeutics，Inc
2.2.1 Business Overview
2.2.2 Longevity and Anti-senescence Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 TA Sciences
2.3.1 Business Overview
2.3.2 Longevity and Anti-senescence Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TA Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Unity Biotechnology
2.4.1 Business Overview
2.4.2 Longevity and Anti-senescence Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 PowerVision Inc.
2.5.1 Business Overview
2.5.2 Longevity and Anti-senescence Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Longevity and Anti-senescence Therapy Market Competition, by Players
3.1 Global Longevity and Anti-senescence Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Longevity and Anti-senescence Therapy Players Market Share
3.2.2 Top 10 Longevity and Anti-senescence Therapy Players Market Share
3.3 Market Competition Trend
4 Global Longevity and Anti-senescence Therapy Market Size by Regions
4.1 Global Longevity and Anti-senescence Therapy Revenue and Market Share by Regions
4.2 North America Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
5 North America Longevity and Anti-senescence Therapy Revenue by Countries
5.1 North America Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
5.2 USA Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
6 Europe Longevity and Anti-senescence Therapy Revenue by Countries
6.1 Europe Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
6.2 Germany Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
6.4 France Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Countries
7.1 Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
7.2 China Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
7.5 India Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
8 South America Longevity and Anti-senescence Therapy Revenue by Countries
8.1 South America Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
8.2 Brazil Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Longevity and Anti-senescence Therapy by Countries
9.1 Middle East and Africa Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
10 Global Longevity and Anti-senescence Therapy Market Segment by Type
10.1 Global Longevity and Anti-senescence Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Longevity and Anti-senescence Therapy Market Forecast by Type (2019-2024)
10.3 Hemolytic Drug Therapy Revenue Growth Rate (2014-2024)
10.4 Gene Therapy Revenue Growth Rate (2014-2024)
10.5 Immunotherapy Revenue Growth Rate (2014-2024)
10.6 Other Stem Cell Therapies Revenue Growth Rate (2014-2024)
11 Global Longevity and Anti-senescence Therapy Market Segment by Application
11.1 Global Longevity and Anti-senescence Therapy Revenue Market Share by Application (2014-2019)
11.2 Longevity and Anti-senescence Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Medical Service Institution Revenue Growth (2014-2019)
11.5 Drug and Device Sales Revenue Growth (2014-2019)
12 Global Longevity and Anti-senescence Therapy Market Size Forecast (2019-2024)
12.1 Global Longevity and Anti-senescence Therapy Market Size Forecast (2019-2024)
12.2 Global Longevity and Anti-senescence Therapy Market Forecast by Regions (2019-2024)
12.3 North America Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
12.6 South America Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Longevity and Anti-senescence Therapy Picture
Table Product Specifications of Longevity and Anti-senescence Therapy
Table Global Longevity and Anti-senescence Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Longevity and Anti-senescence Therapy Revenue Market Share by Types in 2018
Figure Hemolytic Drug Therapy Picture
Figure Gene Therapy Picture
Figure Immunotherapy Picture
Figure Other Stem Cell Therapies Picture
Table Global Longevity and Anti-senescence Therapy Revenue (Million USD) by Application (2014-2024)
Figure Longevity and Anti-senescence Therapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Medical Service Institution Picture
Figure Drug and Device Sales Picture
Table Global Market Longevity and Anti-senescence Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table CohBar Basic Information, Manufacturing Base and Competitors
Table CohBar Longevity and Anti-senescence Therapy Type and Applications
Table CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AgeX Therapeutics，Inc Basic Information, Manufacturing Base and Competitors
Table AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Type and Applications
Table AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table TA Sciences Basic Information, Manufacturing Base and Competitors
Table TA Sciences Longevity and Anti-senescence Therapy Type and Applications
Table TA Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Unity Biotechnology Basic Information, Manufacturing Base and Competitors
Table Unity Biotechnology Longevity and Anti-senescence Therapy Type and Applications
Table Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table PowerVision Inc. Basic Information, Manufacturing Base and Competitors
Table PowerVision Inc. Longevity and Anti-senescence Therapy Type and Applications
Table PowerVision Inc. Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Longevity and Anti-senescence Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue Share by Players (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Players in 2017
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Longevity and Anti-senescence Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Longevity and Anti-senescence Therapy Revenue Market Share in 2018
Figure Global Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Market Share by Regions in 2018
Figure North America Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South America Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table North America Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
Table North America Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Longevity and Anti-senescence Therapy Revenue Market Share by Countries in 2018
Figure USA Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table Europe Longevity and Anti-senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Longevity and Anti-senescence Therapy Revenue Market Share by Countries in 2018
Figure Germany Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UK Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure France Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Longevity and Anti-senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Longevity and Anti-senescence Therapy Revenue Market Share by Countries in 2018
Figure China Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure India Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table South America Longevity and Anti-senescence Therapy Revenue by Countries (2014-2019)
Table South America Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Longevity and Anti-senescence Therapy Revenue Market Share by Countries in 2018
Figure Brazil Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Longevity and Anti-senescence Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Longevity and Anti-senescence Therapy Revenue and Growth Rate (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Type (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Type in 2018
Table Global Longevity and Anti-senescence Therapy Revenue Forecast by Type (2019-2024)
Figure Global Longevity and Anti-senescence Therapy Market Share Forecast by Type (2019-2024)
Figure Global Hemolytic Drug Therapy Revenue Growth Rate (2014-2019)
Figure Global Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Immunotherapy Revenue Growth Rate (2014-2019)
Figure Global Other Stem Cell Therapies Revenue Growth Rate (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue by Application (2014-2019)
Table Global Longevity and Anti-senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Application (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue Share by Application in 2018
Table Global Longevity and Anti-senescence Therapy Revenue Forecast by Application (2019-2024)
Figure Global Longevity and Anti-senescence Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Medical Service Institution Revenue Growth Rate (2014-2019)
Figure Global Drug and Device Sales Revenue Growth Rate (2014-2019)
Figure Global Longevity and Anti-senescence Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Longevity and Anti-senescence Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Longevity and Anti-senescence Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
Figure Europe Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
Figure South America Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Forecast (2019-2024)
老化防止療法の世界市場 2019年版：種類別（遺伝子治療、免疫療法、その他）、用途別（心血管疾患、神経変性疾患、眼科疾患、その他） Scope of the Report: The global Anti-Senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…
- 世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 世界のNK細胞療法市場予測（～2024年）：企業別、地域別、種類・用途別 Description Scope of the Report: The global NK Cell Therapy market is valued at 222.5 million USD in 2018 and is expected to reach 395.4 million USD by the end of 2024, growing at a CAGR of 15.5% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 時差ぼけ治療APPの世界市場 2019年版：種類別（Android、iOS）、用途別（ビジネス旅行者、キャビンクルー、アスリート、季節旅行者、その他） Scope of the Report: The global Jet Lag Therapy APP market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also …